[Federal Register Volume 79, Number 20 (Thursday, January 30, 2014)]
[Notices]
[Pages 4910-4911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-01823]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee:
    Times and Dates: 8:00 a.m.-6:00 p.m., February 26, 2014. 8:00 a.m.-
3:00 p.m., February 27, 2014.
    Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton 
Road NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia 
30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, CDC, 
on the appropriate use of immunizing agents. In addition, under 42 
U.S.C. 1396s, the committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines. 
Further, under provisions of the Affordable Care Act, at section 2713 
of the Public Health Service Act, immunization recommendations of the 
ACIP that have been adopted by the Director, CDC must be covered by 
applicable health plans.
    Matters To Be Discussed: The agenda will include discussions on: 
human papillomavirus vaccines, influenza, pneumococcal conjugate 
vaccine, safety of tetanus, diphtheria, and acellular pertussis 
vaccine/pregnancy, meningococcal vaccines, smallpox vaccine, yellow 
fever vaccine, adult immunization, and vaccine supply. Recommendation 
votes are scheduled for human papillomavirus vaccines and influenza. 
Time will be available for public comment.
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Felicia Betancourt, National 
Center for Immunization and Respiratory Diseases,

[[Page 4911]]

CDC, 1600 Clifton Road NE., MS-A27, Atlanta, Georgia 30333, telephone 
404/639-8836; Email [email protected].
    The meeting is webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP Web 
site: http://www.cdc.gov/vaccines/acip/index.html.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-01823 Filed 1-29-14; 8:45 am]
BILLING CODE 4160-18-P